Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Sebastiano Mercadante. (2017) New drugs for pain management in advanced cancer patients. Expert Opinion on Pharmacotherapy 18:5, pages 497-502.
Read now
Read now
Irma H Benedek, Janet Jobes, Qinfang Xiang & William D Fiske. (2011) Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug Design, Development and Therapy 5, pages 455-463.
Read now
Read now
Roy D. Altman & Howard S. Smith. (2010) Opioid Therapy for Osteoarthritis and Chronic Low Back Pain. Postgraduate Medicine 122:6, pages 87-97.
Read now
Read now
J Turgeon, R Gröning, G Sathyan, J Thipphawong & U Richarz. (2010) The pharmacokinetics of a long-acting OROS hydromorphone formulation. Expert Opinion on Drug Delivery 7:1, pages 137-144.
Read now
Read now
Joseph V Pergolizzi$suffix/text()$suffix/text(), Robert B Raffa & Errol Gould. (2009) Considerations on the use of oxymorphone in geriatric patients. Expert Opinion on Drug Safety 8:5, pages 603-613.
Read now
Read now
Paul Sloan. (2008) Review of oral oxymorphone in the management of pain. Therapeutics and Clinical Risk Management 4:4, pages 777-787.
Read now
Read now
Diane L Chau, Vanessa Walker, Latha Pai & Lwin M Cho. (2008) Opiates and elderly: Use and side effects. Clinical Interventions in Aging 3:2, pages 273-278.
Read now
Read now
Alan K Matsumoto. (2007) Oral extended-release oxymorphone: a new choice for chronic pain relief. Expert Opinion on Pharmacotherapy 8:10, pages 1515-1527.
Read now
Read now
. (2005) Bibliography. Progress in Palliative Care 13:1, pages 15-59.
Read now
Read now
Articles from other publishers (57)
Hironori MawatariTakuya ShinjoTatsuya MoritaHiroyuki KoharaKinomi Yomiya. (2022) Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine. Journal of Palliative Medicine 25:7, pages 1095-1114.
Crossref
Crossref
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham, Jennifer S Hilgart, Andrew J Page & Yuan Chi. (2022) Oxycodone for cancer-related pain. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Crossref
Shanna Babalonis, Sandra D. Comer, Jermaine D. Jones, Paul Nuzzo, Michelle R. Lofwall, Jeanne Manubay, Kevin W. Hatton, Robert A. Whittington & Sharon L. Walsh. (2021) Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans — pilot study outcomes. Psychopharmacology 238:9, pages 2503-2514.
Crossref
Crossref
Lenah Sulaiman S Alhazmi, Manar Abubaker A Bawadood, Alhasan Mohammad S Aljohani, Abdulmajeed Abdullah R Alzahrani, Leena Moshref, Nora Trabulsi & Rana Moshref. (2021) Pain Management in Breast Cancer Patients: A Multidisciplinary Approach. Cureus.
Crossref
Crossref
Robert A. SwarmJudith A. PaiceDoralina L. AnghelescuMadhuri AreJustine Yang BruceSorin BugaMarcin ChwistekCharles CleelandDavid CraigEllin GaffordHeather GreenleeEric HansenArif H. KamalMihir M. KamdarSusan LeGrandSean MackeyM. Rachel McDowellNatalie MorylLisle M. NabellSuzanne Nesbit, Nina O’ConnorMichael W. RabowElizabeth RickersonRebecca ShatskyJill SindtSusan G. UrbaJeanie M. Youngwerth, Lydia J. Hammond & Lisa A. Gurski. (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:8, pages 977-1007.
Crossref
Crossref
Daniel Humberto Pozza, Sara Gil-Mata, Andreia Fontoura Oliveira, Alice Turner, Ramon Andrade De Mello & Newton Barros. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
1071
1113
.
Kai-Kai Guo, Cheng-Qi Deng, Gui-Jun Lu & Guo-Li Zhao. (2018) Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis. BMC Anesthesiology 18:1.
Crossref
Crossref
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham & Jennifer S Hilgart. (2018) Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review. BMJ Supportive & Palliative Care 8:2, pages 117-128.
Crossref
Crossref
Shane E. Peterson, Kathy J. Selvaggi, Bridget Fowler Scullion & Craig D. Blinderman. 2018. Hematology. Hematology
1473
1487
.
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham & Jennifer S Hilgart. (2017) Oxycodone for cancer-related pain. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Hu Ma, Yuan Liu, Lang Huang, Xian-Tao Zeng, Su-Han Jin, Guo-Jun Yue, Xu Tian & Jian-Guo Zhou. (2016) The Adverse Events of Oxycodone in Cancer-Related Pain. Medicine 95:15, pages e3341.
Crossref
Crossref
Shanna Babalonis, Michelle R. Lofwall, Paul A. Nuzzo & Sharon L. Walsh. (2016) Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans. Addiction Biology 21:1, pages 146-158.
Crossref
Crossref
Andrea M. Trescot. 2016. Controlled Substance Management in Chronic Pain. Controlled Substance Management in Chronic Pain
45
62
.
Terri L. Morton, Krishna Devarakonda, Kenneth Kostenbader, Jeannie Montgomery, Thomas Barrett & Lynn Webster. (2015) Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs. Pain Medicine, pages n/a-n/a.
Crossref
Crossref
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham & Jennifer S Hilgart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Daniel Humberto Pozza, Sara Gil-Mata, Andreia Fontoura Oliveira, Alice Turner, Ramon Andrade de Mello & Newton Barros. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
829
866
.
Sebastiano MercadanteGiampiero PorzioVittorio Gebbia. (2014) New Opioids. Journal of Clinical Oncology 32:16, pages 1671-1676.
Crossref
Crossref
Philip J Wiffen, Sheena Derry & R Andrew Moore. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Shalini Dalal, Kimberson C. Tanco & Eduardo Bruera. (2013) State of Art of Managing Pain in Patients With Cancer. The Cancer Journal 19:5, pages 379-389.
Crossref
Crossref
William D. Fiske, Janet Jobes, Qinfang Xiang, Sou-Chan Chang & Irma H. Benedek. (2012) The Effects of Ethanol on the Bioavailability of Oxymorphone Extended-Release Tablets and Oxymorphone Crush-Resistant Extended-Release Tablets. The Journal of Pain 13:1, pages 90-99.
Crossref
Crossref
S King, K Forbes, GW Hanks, CJ Ferro & EJ Chambers. (2011) A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project. Palliative Medicine 25:5, pages 525-552.
Crossref
Crossref
Samuel James King, Colette Reid, Karen Forbes & Geoffrey Hanks. (2011) A systematic review of oxycodone in the management of cancer pain. Palliative Medicine 25:5, pages 454-470.
Crossref
Crossref
Shalini Dalal & Eduardo Bruera. (2011) Assessment and Management of Pain in the Terminally Ill. Primary Care: Clinics in Office Practice 38:2, pages 195-223.
Crossref
Crossref
Judith A. Paice & Betty Ferrell. (2011) The management of cancer pain. CA: A Cancer Journal for Clinicians 61:3, pages 157-182.
Crossref
Crossref
Wojciech Leppert. (2010) Role of oxycodone and oxycodone/naloxone in cancer pain management. Pharmacological Reports 62:4, pages 578-591.
Crossref
Crossref
Fadia Mayyas, Peter Fayers, Stein Kaasa & Ola Dale. (2010) A Systematic Review of Oxymorphone in the Management of Chronic Pain. Journal of Pain and Symptom Management 39:2, pages 296-308.
Crossref
Crossref
Drew A. Rosielle. (2010) Oral Oxymorphone #181. Journal of Palliative Medicine 13:1, pages 78-79.
Crossref
Crossref
A.H. Ghodse & S. Galea. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
183
224
.
. 2010. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs. Meyler's Side Effects of Analgesics and Anti-inflammatory Drugs
1
164
.
Timothy W. Victor, Nancy A. Alvarez & Errol Gould. (2009) Opioid Prescribing Practices in Chronic Pain Management: Guidelines Do Not Sufficiently Influence Clinical Practice. The Journal of Pain 10:10, pages 1051-1057.
Crossref
Crossref
Helena Knotkova, Perry G. Fine & Russell K. Portenoy. (2009) Opioid Rotation: The Science and the Limitations of the Equianalgesic Dose Table. Journal of Pain and Symptom Management 38:3, pages 426-439.
Crossref
Crossref
Brian E. McGeeney. (2009) Pharmacological Management of Neuropathic Pain in Older Adults: An Update on Peripherally and Centrally Acting Agents. Journal of Pain and Symptom Management 38:2, pages S15-S27.
Crossref
Crossref
Judith A. Paice. (2009) Clinical Challenges: Chemotherapy-Induced Peripheral Neuropathy. Seminars in Oncology Nursing 25:2, pages S8-S19.
Crossref
Crossref
Henry McQuayRaymond S. Sinatra. 2009. Acute Pain Management. Acute Pain Management
188
203
.
Michael J. Brennan. (2009) Summary of Short-term and Long-term Oxymorphone Efficacy (Pain) Studies in Low Back Pain, Cancer Pain, Osteoarthritis, and Neuropathic Pain. Pain Medicine 10:suppl 1, pages S11-S19.
Crossref
Crossref
Howard S. Smith. (2009) Clinical Pharmacology of Oxymorphone. Pain Medicine 10:suppl 1, pages S3-S10.
Crossref
Crossref
David A. Fishbain. (2009) Oxymorphone Status. Pain Medicine 10:suppl 1, pages S1-S2.
Crossref
Crossref
John H. Peniston & Errol Gould. (2009) Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clinical Therapeutics 31:2, pages 347-359.
Crossref
Crossref
Howard S. Smith & Gary McCleane. 2009. Current Therapy in Pain. Current Therapy in Pain
408
421
.
Richard Rauck, Tina Ma, Rosemary Kerwin & Harry Ahdieh. (2008) Titration with Oxymorphone Extended Release to Achieve Effective Long-Term Pain Relief and Improve Tolerability in Opioid-Naive Patients with Moderate to Severe Pain. Pain Medicine 9:7, pages 777-785.
Crossref
Crossref
Joseph Pergolizzi, Rainer H Böger, Keith Budd, Albert Dahan, Serdar Erdine, Guy Hans, Hans-Georg Kress, Richard Langford, Rudolf Likar, Robert B. Raffa & Paola Sacerdote. (2008) Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone). Pain Practice 8:4, pages 287-313.
Crossref
Crossref
Oscar A. de Leon-Casasola. (2008) Current Developments in Opioid Therapy for Management of Cancer Pain. The Clinical Journal of Pain 24:Supplement 10, pages S3-S7.
Crossref
Crossref
Takahiro Suzuki, Miyuki Morishita, Eiki Ito, Motoki Matsuura, Ryoichi Tanaka & Tsuyoshi Saito. (2008) Analgesic Efficacy of Controlled-release Oxycodone in Patients With Uterine or Ovarian Cancer. American Journal of Therapeutics 15:1, pages 31-35.
Crossref
Crossref
Perry G. Fine & David Casarett. 2008. Raj's Practical Management of Pain. Raj's Practical Management of Pain
1159
1177
.
James F. Cleary. (2007) The Pharmacologic Management of Cancer Pain. Journal of Palliative Medicine 10:6, pages 1369-1394.
Crossref
Crossref
Gary McCleane & Howard S. Smith. (2007) Opioids for Persistent Noncancer Pain. Anesthesiology Clinics 25:4, pages 787-807.
Crossref
Crossref
Kevin W Chamberlin, Mark Cottle, Rebecca Neville & Jennifer Tan. (2016) Oral Oxymorphone for Pain Management. Annals of Pharmacotherapy 41:7-8, pages 1144-1152.
Crossref
Crossref
David R. P. Guay. (2007) <b>Use of Oral Oxymorphone in the Elderly</b>. The Consultant Pharmacist 22:5, pages 417-430.
Crossref
Crossref
Gary McCleane & Howard S. Smith. (2007) Opioids for Persistent Noncancer Pain. Medical Clinics of North America 91:2, pages 177-197.
Crossref
Crossref
Hongming Pan, Zaiyun Zhang, Yiping Zhang, Nong Xu, Liqin Lu, Chunfeng Dou, Yong Guo, Shixiu Wu, Jianhua Yue, Dongping Wu & Yuechu Dai. (2007) Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain. Clinical Drug Investigation 27:4, pages 259-267.
Crossref
Crossref
Alan Kivitz, Carl Ma, Harry Ahdieh & Bradley S. Galer. (2006) A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clinical Therapeutics 28:3, pages 352-364.
Crossref
Crossref
Mellar P Davis. (2006) Management of Cancer Pain. American Journal of Cancer 5:3, pages 171-182.
Crossref
Crossref
Richard J. Bodnar & Gad E. Klein. (2005) Endogenous opiates and behavior: 2004. Peptides 26:12, pages 2629-2711.
Crossref
Crossref
Alan K. Matsumoto, Najib Babul & Harry Ahdieh. (2005) Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial. Pain Medicine 6:5, pages 357-366.
Crossref
Crossref
Martin E. Hale, Chris Dvergsten & Joseph Gimbel. (2005) Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study. The Journal of Pain 6:1, pages 21-28.
Crossref
Crossref
Joseph Gimbel & Harry Ahdieh. (2004) The Efficacy and Safety of Oral Immediate-Release Oxymorphone for Postsurgical Pain. Anesthesia & Analgesia, pages 1472-1477.
Crossref
Crossref
CARLA IDA RIPAMONTI & CLAUDIA BAREGGI. 2010. Cancer Pain. Cancer Pain
195
229
.